Post Menopausal Osteoporosis Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
To determine the clinical safety and efficacy of abaloparatide transdermal in otherwise healthy postmenopausal women with osteoporosis as assessed by changes in bone mineral density (BMD) and serum markers of bone metabolism when compared to transdermal placebo and abaloparatide injection for 6 months of treatment.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01732770 -
Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
|
Phase 4 | |
Completed |
NCT00377234 -
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
|
Phase 4 | |
Recruiting |
NCT05571514 -
Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis
|
N/A | |
Completed |
NCT00048074 -
DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
|
Phase 3 | |
Completed |
NCT02347865 -
Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
|
||
Completed |
NCT00545480 -
SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
|
Phase 4 | |
Completed |
NCT00303485 -
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
|
Phase 4 | |
Active, not recruiting |
NCT05332626 -
Lactobacillus Acidophilus and Postmenopausal Osteoporosis Women
|
N/A | |
Completed |
NCT00545090 -
ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
|
Phase 4 | |
Completed |
NCT02598934 -
A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis
|
Phase 4 | |
Completed |
NCT01290094 -
A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis
|
Phase 3 | |
Completed |
NCT00048061 -
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
|
Phase 3 |